Ellia Cytocare Pvt. Ltd.
Ellia Cytocare is a pioneering pharmaceutical company dedicated to advancing oncology through innovative and targeted cancer therapies. With a focus on research, quality, and patient-centric solutions, the company aims to provide effective treatments worldwide. Their mission emphasizes innovation, safety, and accessibility, striving to make cancer a manageable condition and ultimately conquer the disease. Ellia Cytocare operates state-of-the-art manufacturing facilities, adheres to strict regulatory standards, and collaborates globally to deliver high-quality anticancer products. The company’s vision is to lead the anticancer revolution with breakthroughs in treatment efficacy, safety, and personalized care, aiming for a future where cancer is no longer a life-threatening disease.
Industries
Nr. of Employees
small (1-50)
Ellia Cytocare Pvt. Ltd.
Products
Cytotoxic injectable oncology formulations (liquid)
Liquid injectable anticancer agents supplied in sterile form for IV administration.
Lyophilized (freeze-dried) oncology injections
Lyophilized sterile injections requiring reconstitution prior to administration, intended to improve stability for select oncology drugs.
Oral targeted therapy tablets and capsules
Oral small-molecule oncology medicines provided as tablets or capsules for outpatient and chronic therapy settings.
Hematology oncology injectables and oral agents
Products intended for hematologic malignancies including injectable and oral formulations.
Supportive-care oncology products
Medications and formulations aimed at mitigating chemotherapy side effects and improving patient comfort during cancer treatment.
Product categories: Solid tumor, Hematology, Supportive care
Organized portfolio covering major oncology categories: solid tumor treatments, hematology therapeutics, and supportive-care agents.
Cytotoxic injectable oncology formulations (liquid)
Liquid injectable anticancer agents supplied in sterile form for IV administration.
Lyophilized (freeze-dried) oncology injections
Lyophilized sterile injections requiring reconstitution prior to administration, intended to improve stability for select oncology drugs.
Oral targeted therapy tablets and capsules
Oral small-molecule oncology medicines provided as tablets or capsules for outpatient and chronic therapy settings.
Hematology oncology injectables and oral agents
Products intended for hematologic malignancies including injectable and oral formulations.
Supportive-care oncology products
Medications and formulations aimed at mitigating chemotherapy side effects and improving patient comfort during cancer treatment.
Product categories: Solid tumor, Hematology, Supportive care
Organized portfolio covering major oncology categories: solid tumor treatments, hematology therapeutics, and supportive-care agents.
Services
Manufacturing services for injectable (liquid and lyophilized) and oral solid oncology products in GMP-compliant facilities with scalable capacity.
End-to-end regulatory support including preparation and submission of registration dossiers, MAAs, labeling compliance, clinical trial approvals, and post-marketing surveillance.
Research and development focused on oncology targets, biomarker-driven approaches, and formulation development for injectables and oral dosage forms.
Analytical testing and QC services including chromatographic testing to ensure batch purity, potency and compliance with specifications.
Services to support product export, regional labeling adaptation, and market entry for multiple international regions.
Manufacturing services for injectable (liquid and lyophilized) and oral solid oncology products in GMP-compliant facilities with scalable capacity.
End-to-end regulatory support including preparation and submission of registration dossiers, MAAs, labeling compliance, clinical trial approvals, and post-marketing surveillance.
Research and development focused on oncology targets, biomarker-driven approaches, and formulation development for injectables and oral dosage forms.
Analytical testing and QC services including chromatographic testing to ensure batch purity, potency and compliance with specifications.
Services to support product export, regional labeling adaptation, and market entry for multiple international regions.
Expertise Areas
- Oncology drug development
- Sterile injectable and lyophilized formulation manufacturing
- Oral solid-dose formulation and production
- Regulatory affairs and international product registration
Key Technologies
- Lyophilization (freeze-drying)
- Aseptic fill-finish / sterile processing
- High-performance liquid chromatography (HPLC)
- Automated production and packaging lines
News & Updates
Join Us in Raising Awareness about Head and Neck Cancer. World Head and Neck Cancer Day is observed annually on July 27th to raise awareness about head and neck cancers and promote early detection and treatment.
October is recognized worldwide as Breast Cancer Awareness Month, a time dedicated to raising awareness about breast cancer, encouraging early detection and screening, and supporting those affected by the disease.
Lung Cancer Awareness Month, observed every November, is a time dedicated to raising awareness about lung cancer, its risk factors, and the importance of early detection.
Join Us in Raising Awareness about Head and Neck Cancer. World Head and Neck Cancer Day is observed annually on July 27th to raise awareness about head and neck cancers and promote early detection and treatment.
October is recognized worldwide as Breast Cancer Awareness Month, a time dedicated to raising awareness about breast cancer, encouraging early detection and screening, and supporting those affected by the disease.
Lung Cancer Awareness Month, observed every November, is a time dedicated to raising awareness about lung cancer, its risk factors, and the importance of early detection.